此页面是自动翻译的，不保证翻译的准确性。请参阅 英文版 对于源文本。

Evaluation of a Toolkit to Improve Cardiovascular Disease Screening and Treatment for People With Type 2 Diabetes

2014年11月21日 更新者：Sunnybrook Health Sciences Centre
Diabetes is a common and serious chronic disease. However, there is a large gap between the level of care that people should receive (based on research and guidelines) and the level of care they actually receive. With the release of their 2008 Clinical Practice Guidelines, the Canadian Diabetes Association has a strategy to improve heart disease screening and treatment for people with diabetes. This study will evaluate whether the strategy works. The focus of the strategy was to give all family physicians in Canada a Toolkit in June 2009 to help them delivery better care for their diabetic patients. In Ontario, only half of doctors received this Toolkit. We will compare the quality of care received by diabetic patients whose doctors received this Toolkit versus those who doctors did not.

研究概览

地位

完全的

条件

干预/治疗

详细说明

A cardiovascular disease Toolkit was developed by the Canadian Diabetes Association and mailed to family physician with the Spring/Summer 2009 edition of the newsletter, Canadian Diabetes. The Toolkit was packaged in a brightly-coloured box with Canadian Diabetes Association branding, and contained: 1) an introductory letter from the Chair of the practice guidelines' Dissemination and Implementation Committee; 2) an eight page summary of selected sections of the practice guidelines targeted towards primary care physicians; 3) a four page synopsis of the key guideline elements pertaining to cardiovascular disease risk; 4) a small double-sided laminated card with a simplified algorithm for cardiovascular risk assessment, vascular protection strategies and screening for cardiovascular disease; and 5) a pad of tear-off sheets for patients with a cardiovascular risk self-assessment tool and a list of recommended risk reduction strategies.

研究类型

介入性

注册 (实际的)

1592

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息，以及有关进行该研究的地点的信息。

学习地点

  • 加拿大
    • Ontario
      • Toronto、Ontario、加拿大、M4N 3M5
        • Institute for Clinical Evaluative Sciences

参与标准

研究人员寻找符合特定描述的人，称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Patient with diagnosed diabetes
  • Seen in the office of a participating family physician at least once between July 2009 and April 2010

  • At high risk for cardiovascular events:

    • Previous cardiovascular disease (including AMI, angina, stroke, TIA, claudication); or
    • Men aged >= 45 years, women aged >= 50 years; or

    • Men aged < 45 years, women aged < 50 years with at least one of the following:

      1. Macrovascular disease (silent myocardial infarction, or evidence of peripheral arterial, carotid or cerebrovascular disease)
      2. Microvascular disease (nephropathy or retinopathy)
      3. Family history of premature coronary or cerebrovascular disease in a first-degree relative
      4. Duration of diabetes > 15 years with age > 30 years

学习计划

本节提供研究计划的详细信息，包括研究的设计方式和研究的衡量标准。

研究是如何设计的？

设计细节

  • 主要用途：卫生服务研究
  • 分配：随机化
  • 介入模型：并行分配
  • 屏蔽：单身的

武器和干预

参与者组/臂
干预/治疗
实验性的：干涉
其他：工具包
心血管疾病工具包由加拿大糖尿病协会邮寄给家庭医生，并附有 2009 年春夏季刊《加拿大糖尿病》。 （2009 年 6 月寄出。） 该工具包包括针对初级保健医生的实践指南的选定部分的摘要；有关心血管疾病风险的关键信息概要；带有简化心血管风险评估和治疗算法的层压卡；以及为带有心血管风险自我评估工具的患者准备的一叠可撕纸。
其他：控制
其他：Control
The Spring/Summer 2009 issue of the quarterly newsletter, Canadian Diabetes, mailed on its own. The Cardiovascular Toolkit was mailed to Control arm physicians with the May 2010 issue of the newsletter.

研究衡量的是什么？

主要结果指标

结果测量
大体时间
Patient is receiving a statin
大体时间：July 2009 to April 2010
July 2009 to April 2010

次要结果测量

结果测量
大体时间
Patient is receiving an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker
大体时间：July 2009 to April 2010
July 2009 to April 2010
A1c level
大体时间：Last observation between July 2009 and April 2010
Last observation between July 2009 and April 2010
Blood pressure level
大体时间：Last observation between July 2009 and April 2010
Last observation between July 2009 and April 2010
LDL-cholesterol level
大体时间：Last observation between July 2009 and April 2010
Last observation between July 2009 and April 2010
Total- to HDL-cholesterol ratio
大体时间：Last observation between July 2009 and April 2010
Last observation between July 2009 and April 2010
Body mass index
大体时间：Last observation between July 2009 and April 2010
Last observation between July 2009 and April 2010
Waist circumference
大体时间：Last observation between July 2009 and April 2010
Last observation between July 2009 and April 2010
Change in treatment recommended following an A1c level above 0.070
大体时间：At the next patient visit after the abnormal measurement
At the next patient visit after the abnormal measurement
Change in treatment recommended following a systolic blood pressure above 130 or a diastolic blood pressure above 80
大体时间：At the patient visit of the abnormal measurement
At the patient visit of the abnormal measurement
Change in treatment recommended following an LDL-cholesterol level above 2.0 mmol/L
大体时间：At the next patient visit after the abnormal measurement
At the next patient visit after the abnormal measurement

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

赞助

Sunnybrook Health Sciences Centre

合作者

Unity Health Toronto
Institute for Clinical Evaluative Sciences

调查人员

  • 首席研究员：Baiju R Shah, MD PhD、Institute for Clinical Evaluative Sciences

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查，以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2010年6月1日

初级完成 (实际的)

2011年5月1日

研究完成 (实际的)

2011年5月1日

研究注册日期

首次提交

2009年12月2日

首先提交符合 QC 标准的

2009年12月3日

首次发布 (估计)

2009年12月4日

研究记录更新

最后更新发布 (估计)

2014年11月24日

上次提交的符合 QC 标准的更新

2014年11月21日

最后验证

2014年11月1日

更多信息

与本研究相关的术语

关键字

其他相关的 MeSH 术语

其他研究编号

  • Shah-1

此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.

订阅